BioSpace

Cerevance Parkinson’s drug shortens 'off time' in Ph. 3, paving path to FDA

The Takeda spinout showed that a high dose of solengepras can shorten the periods during which difficult Parkinson’s disease symptoms like involuntary movements and sleepiness.

By BioSpace

1 min read
Cerevance Parkinson’s drug shortens 'off time' in Ph. 3, paving path to FDA
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights